Related Experiment Video
Updated: May 4, 2026

05:42
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
2.9K
Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval
Alan Christie1, Neil McKay2, Fiona Nussey1
1Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
Gynecologic Oncology Case Reports
|December 28, 2013
Abstract:
•Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids.•Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease.•Prognosis of ovarian cancer in context of dermatomyositis is poor.

